Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
AssigneeReata Pharmaceuticals, Inc.
InventorsEric ANDERSON, Xin JIANG, Xiaofeng LIU, Melean VISNICK
Life of this patent
Estimating the term…
Abstract
This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.
Claims31
1-18. (canceled)
A compound of the formula:
- wherein:
- Y is cyano or —C(O)Ra, wherein
- Ra is:
- hydrogen, hydroxy, halo, amino, hydroxyamino, azido or mercapto;
- or
- alkyl(C≦12), alkenyl(C≦12), alkynyl(C≦12), aryl(C≦12), aralkyl(C≦12), heteroaryl(C≦12), heteroaralkyl(C≦12), alkoxy(C≦12), alkenyl-oxy(C≦12), alkynyloxy(C≦12), aryloxy(C≦12), aralkoxy(C≦12), heteroaryloxy(C≦12), heteroaralkoxy(C≦12), acyloxy(C≦12), alkylamino(C≦12), dialkylamino(C≦12), alkoxyamino(C≦12), alkenylamino(C≦12), alkynylamino(C≦12), arylamino(C≦12), aralkylamino(C≦12), heteroarylamino(C≦12), heteroaralkyl-amino(C≦12), alkylsulfonylamino(C≦12), amido(C≦12), alkylthio(C≦12), alkenylthio(C≦12), alkynylthio(C≦12), arylthio(C≦12), aralkylthio(C≦12), heteroarylthio(C≦12), heteroaralkylthio(C≦12), acylthio(C≦12), alkylammonium(C≦12), alkylsulfonium(C≦12), alkylsilyl(C≦12), or a substituted version of any of these groups;
- X is ORb, NRbRc, or SRb, wherein Rb and Rc are each independently:
- hydrogen;
- alkyl(C≦8), aryl(C≦8), aralkyl(C≦8), acyl(C≦8), or a substituted version of any of these groups;
- or
- provided that Rb is absent when the atom to which it is bound is part of a double bond, further provided that when Rb is absent the atom to which it is bound is part of a double bond;
- and
- R1 is:
- hydrogen, cyano, hydroxy, halo or amino;
- or
- alkyl(C≦8), alkenyl(C≦8), alkynyl(C≦8), aryl(C≦8), aralkyl(C≦8), heteroaryl(C≦8), heteroaralkyl(C≦8), acyl(C≦8), alkoxy(C≦8), aryloxy(C≦8), acyloxy(C≦8), alkylamino(C≦8), arylamino(C≦8), amido(C≦8), or a substituted version of any of these groups;
- or a salt or tautomer thereof.
A compound of the formula:
- wherein:
- Y is cyano or —C(O)Ra, wherein
- Ra is:
- hydrogen, hydroxy, halo, amino, hydroxyamino, azido or mercapto;
- or
- alkyl(C≦12), alkenyl(C≦12), alkynyl(C≦12), aryl(C≦12), aralkyl(C≦12), heteroaryl(C≦12), heteroaralkyl(C≦12), alkoxy(C≦12), alkenyl-oxy(C≦12), alkynyloxy(C≦12), aryloxy(C≦12), aralkoxy(C≦12), heteroaryloxy(C≦12), heteroaralkoxy(C≦12), acyloxy(C≦12), alkylamino(C≦12), dialkylamino(C≦12), alkoxyamino(C≦12), alkenylamino(C≦12), alkynylamino(C≦12), arylamino(C≦12), aralkylamino(C≦12), heteroarylamino(C≦12), heteroaralkyl-amino(C≦12), alkylsulfonylamino(C≦12), amido(C≦12), alkylthio(C≦12), alkenylthio(C≦12), alkynylthio(C≦12), arylthio(C≦12), aralkylthio(C≦12), heteroarylthio(C≦12), heteroaralkylthio(C≦12), acylthio(C≦12), alkylammonium(C≦12), alkylsulfonium(C≦12), alkylsilyl(C≦12), or a substituted version of any of these groups;
- X is ORb, NRbRc, or SRb, wherein Rb and Rc are each independently:
- hydrogen;
- alkyl(C≦8), aryl(C≦8), aralkyl(C≦8), acyl(C≦8), or a substituted version of any of these groups;
- or
- provided that Rb is absent when the atom to which it is bound is part of a double bond, further provided that when Rb is absent the atom to which it is bound is part of a double bond;
- and
- R1 is:
- hydrogen, cyano, hydroxy, halo or amino;
- or
- alkyl(C≦8), alkenyl(C≦8), alkynyl(C≦8), aryl(C≦8), aralkyl(C≦8), heteroaryl(C≦8), heteroaralkyl(C≦8), acyl(C≦8), alkoxy(C≦8), aryloxy(C≦8), acyloxy(C≦8), alkylamino(C≦8), arylamino(C≦8), amido(C≦8), or a substituted version of any of these groups;
- R′ is hydroxy, alkoxy(C≦12), substituted alkoxy(C≦12), aryloxy(C≦12), substituted aryloxy(C≦12), aralkoxy(C≦12), substituted aralkoxy(C≦12), acyloxy(C≦12), or substituted acyloxy(C≦12);
- or a salt or tautomer thereof.
21-23. (canceled)
29-30. (canceled)
33-36. (canceled)
41-47. (canceled)
50-54. (canceled)
56-68. (canceled)
71-113. (canceled)
(canceled)
118-254. (canceled)
Dependencies are inferred from the claim text.